journal article·2013-02-13

Human Serum Lipoproteins Influence Protein Deposition Patterns on Nanoparticle Surfaces

Ameena Meerasa, Jasper G. Huang, Frank X. Gu

Publisher page

Abstract

We report the concentration-dependent adsorption of serum lipoproteins onto silica nanoparticles, wherein elevated lipid levels deter complement activation. Two clinically relevant serum lipid levels - corresponding to low and borderline high levels in normal, healthy adults - were used to examine the influence of lipoprotein concentration on nanoparticle complement activation. Human serum albumin was used to study protein adsorption in the presence of lipoproteins. Preferential adsorption of high affinity lipoproteins led to greater lipid fractions in the protein corona, shielding particles from complement activation. These findings have significant implications for the design of intravenously administered carriers with biocompatible surface chemistries.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Blood properties and coagulation · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering and ‡Waterloo Institute for Nanotechnology, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1

References (15)

Show source-provided references
1. Hellstrand E. · FEBS J. · 2009 · 276 · 337210.1111/j.1742-4658.2009.07062.x ↗
2. Cedervall T. · Angew. Chem., Int. Ed. · 2007 · 46 · 575410.1002/anie.200700465 ↗
3. Casals E. · ACS Nano · 2010 · 4 · 362310.1021/nn901372t ↗
4. Lundqvist M. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1426510.1073/pnas.0805135105 ↗
5. Karmali P. P. · Expert Opin. Drug Delivery · 2011 · 8 · 34310.1517/17425247.2011.554818 ↗
6. Aggarwal P. · Adv. Drug Delivery Rev. · 2009 · 61 · 42810.1016/j.addr.2009.03.009 ↗
7. Meerasa A. · Curr. Drug Delivery · 2011 · 8 · 29010.2174/156720111795256165 ↗
8. Dobrovolskaia M. A. · Mol. Pharm. · 2008 · 5 · 48710.1021/mp800032f ↗
9. Kabat E. A. · 1964
10. Hlady V. · Colloids Surf. · 1988 · 34 · 17110.1016/0166-6622(88)80095-7 ↗
11. Malmsten M. · J. Colloid Interface Sci. · 2000 · 224 · 33810.1006/jcis.1999.6689 ↗
12. Moghimi S. · J. Biochim. Biophys. Acta, Mol. Basis Dis. · 2004 · 1689 · 10310.1016/j.bbadis.2004.02.005 ↗
13. Pasqui A. · Clin. Exp. Med. · 2002 · 2 · 3310.1007/s102380200004 ↗
14. Hamilton K. · J. Clin. Invest. · 1991 · 88 · 183310.1172/JCI115504 ↗
15. Cleeman J. I. · J. Am. Med. Assoc. · 2001 · 285 · 248610.1001/jama.285.19.2486 ↗